8-K: Sleep Number Reports Steep Q3 Losses, Revises 2025 Outlook

Sentiment:

Quarterly Report


Sleep Number Corporation announced a significant net loss and revenue decline for Q3 2025, alongside a downward revision of its full-year financial outlook, despite securing an extended bank agreement.

Worse than expectedQ3 2025 net sales declined by 19.6% year-over-year to $343 million.Reported a net loss of $40 million in Q3 2025, compared to a $3 million net loss in Q3 2024.Adjusted EBITDA for Q3 2025 decreased by 52% to $13 million.The full-year 2025 outlook was revised downwards, projecting lower net sales (approximately $1.4 billion), significantly lower adjusted EBITDA (approximately $70 million), and negative free cash flow (approximately $50 million).

Summary

  • Reported net sales of $343 million for Q3 2025, a 19.6% decrease compared to Q3 2024.
  • Delivered a gross profit margin of 59.9% in Q3 2025, slightly down from 60.8% in the prior year period.
  • Reduced third quarter operating expenses by $44.8 million, or 18% year-over-year, before restructuring and other non-recurring costs.
  • Reported a net loss of $40 million for Q3 2025, a significant increase from a $3 million net loss in Q3 2024.
  • Adjusted EBITDA for Q3 2025 was $13 million, down $14 million or 52% compared to the same period last year.
  • Secured an amendment and extension of its bank agreement through 2027, providing increased financial flexibility.
  • On track to exceed 2025 cost savings target and has a streamlined organization to execute a business turnaround.
  • Revised full-year 2025 outlook now expects net sales of approximately $1.4 billion, gross profit margin of approximately 60%, adjusted EBITDA of approximately $70 million, and negative free cash flow of approximately $50 million.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant declines in sales and profitability, a substantial net loss, and a downward revision of the full-year outlook. While the bank agreement extension provides some stability, the company is undergoing a 'full turnaround' with acknowledged 'more challenges than expected,' indicating a difficult operating environment and uncertain recovery path.

Positives

  • Successfully amended and extended its bank agreement through 2027, enhancing financial flexibility and covenant terms.
  • Reduced third quarter operating expenses by $44.8 million, or 18% year-over-year, before restructuring and other non-recurring costs, demonstrating cost control efforts.
  • On track to exceed its 2025 cost savings target, indicating effective expense management.
  • The company's leverage ratio of 5.0x EBITDAR is below the amended covenant maximum of 5.25x, providing some headroom.

Negatives

  • Net sales for Q3 2025 decreased by 19.6% to $343 million, driven by lower volume and a reduced store count.
  • Reported a net loss of $40 million for Q3 2025, a substantial deterioration from a $3 million net loss in Q3 2024.
  • Adjusted EBITDA declined by 52% to $13 million in Q3 2025, reflecting a significant drop in profitability.
  • Year-to-date free cash flow was a use of $17.0 million, compared to a positive free cash flow of $33.6 million in the prior year.
  • The full-year 2025 financial outlook has been revised downwards, projecting lower net sales, lower adjusted EBITDA, and negative free cash flow.
  • Incurred $41 million in restructuring and other non-recurring costs in Q3 2025, primarily due to severance, contract termination, and asset impairment charges.

Risks

  • Significant decline in net sales due to lower volume and reduced store count, impacting revenue generation.
  • Increased net losses and reduced Adjusted EBITDA, indicating ongoing profitability challenges.
  • Substantial restructuring costs and other non-recurring expenses impacting financial performance.
  • Operational challenges and 'more challenges than expected' in executing a company-wide turnaround.
  • Constraints imposed by the company's capital structure, despite the bank agreement amendment.
  • The company is in a 'full turnaround' phase, which inherently carries execution risks and uncertainty.

Future Outlook

The company has revised its full-year 2025 outlook, now expecting net sales of approximately $1.4 billion, a gross profit margin of approximately 60%, operating expenses (excluding restructuring) of approximately $825 million, adjusted EBITDA of approximately $70 million, and negative free cash flow of approximately $50 million. Management is optimistic about executing a business turnaround in 2026, with plans to invest in growth and make strategic shifts in product, brand positioning, and distribution.

Management Comments

  • "We have successfully executed an amendment and extension of our bank agreement through 2027, giving us greater flexibility to further our turnaround plans. With this new agreement, combined with meaningful fixed cost reductions achieved in 2025, we will invest in growth in 2026."
  • "My learnings thus far make me incredibly optimistic about Sleep Number's future and the ability to create significant shareholder value in the coming years. To be clear, this is a full turnaround of an inherently great company."
  • "As in many situations like this, there were more challenges than I expected, which required us to move extremely fast to fix the business. The pace of our work, along with constraints imposed by our capital structure, has made the first six months difficult. However, we have accomplished a lot and are optimistic that this work positions us to execute the turnaround in 2026."

Industry Context

The company's significant decline in sales and profitability, coupled with the CEO's comments about 'pressures on the business' and a 'full turnaround,' suggests that the broader bedding or home goods retail industry may be experiencing headwinds, or that Sleep Number is facing company-specific challenges that are more severe than general market trends. The focus on cost reductions and strategic shifts indicates an effort to adapt to a challenging operating environment.

Stakeholder Impact

  • Shareholders: Likely negative impact due to significant financial losses, reduced sales, and a downward revised outlook, potentially leading to share price depreciation. Long-term impact depends on the success of the turnaround strategy.
  • Employees: Impacted by restructuring activities, which include severance and employee-related benefits, suggesting potential job reductions or organizational changes.
  • Creditors: The amendment and extension of the bank agreement through 2027 indicates active management of debt obligations and provides financial flexibility, which is generally positive for creditors by reducing immediate default risk.

Next Steps

  • Invest in growth in 2026.
  • Execute the company-wide business turnaround in 2026.
  • Implement strategic shifts in product, brand positioning, and distribution to drive consumer demand.
  • Management will host a conference call on November 5, 2025, to discuss the results.

Key Dates

DateDescription
September 27, 2025End of the fiscal third quarter for Sleep Number Corporation.
November 5, 2025Date of the 8-K report and press release announcing Q3 2025 results; also the date of the management conference call.
2026Company plans to invest in growth and execute its business turnaround strategy.
2027New bank agreement amendment and extension is valid through this year, providing financial flexibility.

Recommendation

strong sell

The company's Q3 2025 results show a severe deterioration in financial performance, with a 19.6% drop in net sales, a $40 million net loss, and a 52% decline in Adjusted EBITDA. The revised full-year 2025 outlook projects continued negative free cash flow and significantly lower profitability. While the bank agreement extension offers some liquidity, the CEO's candid remarks about a 'full turnaround' and 'more challenges than expected' underscore deep operational issues and a high degree of uncertainty. These factors suggest a challenging path to recovery, making the stock a high-risk investment with a strong likelihood of further downside in the short to medium term.

Keywords

Sleep Number, SNBR, Q3 2025 Earnings, Financial Results, Net Loss, Adjusted EBITDA, Turnaround Plan, Bank Agreement, Cost Savings, Retail Sales, Bedding Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.